CHNC China Infrastructure Construct

CHNC Announces a New Member of Its Board of Directors

CHNC Announces a New Member of Its Board of Directors

HOUSTON, TX, Oct. 20, 2021 (GLOBE NEWSWIRE) -- via -- China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) announces that Elizabeth Hernandez, a member of its board of directors and its Chief Operating Officer, has left the Company (July 28th, 2021) and is no longer serving in these capacities. The Company is not aware of her future plans.

Nevertheless, this position will not remain empty and has been filled with one of the team’s responsible architects of International Strategic Alliances. “We are pleased to announce that we will be welcoming one of our very best as a member of our Board of Directors, Anne Marie Graham, Attorney at Law and CHNC’s Director of International Markets,” says Henry Levinski, CHNC’s Treasurer. 

Since her arrival at CHNC she has contributed to the Company her years of business acumen, as well as her experience as a corporate lawyer, developing partnerships with international academic institutions.

Previous to her new responsibilities, she was in charge of the well-known Cannabis World Journals magazine. Ms. Graham was instrumental in achieving successful alliances with ICESI University in Cali, as well as the negotiations with a variety of Latin American academic institutions to expand the reach of CHNC all over the world. As a result, she received the title of CLO.

As an attorney at law, she has made sure the company is at the top of the game in legal developments within the industry and has kept our audiences informed of the regulatory frameworks that are sometimes so hard to manage within this industry. Her vast background in public speaking, as attested with her numerous victories in contests such as the III Iberoamerican Tax Moot Court held by the University of Florida in Gainesville, made her a keen mediator in every new deal we have struck, and her legal background has given us the advantage in each contract we have drafted. The lion’s share of our growth as a company is due to her excellent management skills which turned our expanding ranks into a well-oiled machine.

“As one of the Directors of the company I have witnessed production and execution and now I am eager to fulfill my duties as a Member of the Board moving CHNC forward to higher profitability while continuing to expand our grasp in new and exciting markets,” states Anne Marie Graham.

We wish her the very best in this new professional turn in her career and having had the pleasure to work alongside her, we now are excited to see the great new lengths this company will reach with the help of her guidance in her new responsibilities.

To learn more visit: 

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

For more information contact us at:



817/528-2475 for English

214/733-0868 for Spanish



EN
20/10/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 ...

Houston, Texas--(Newsfile Corp. - January 21, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today that it is in the evaluation stage of a potential financing transaction under Regulation A (Reg A), in an estimated amount in the order of $1,000,000, subject to change, internal review, and applicable market and compliance conditions.CBIH clarifies that this communication reflects a serious corporate and executive planning approach intended to protect business value and accelerate operati...

 PRESS RELEASE

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr....

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today the launch of its Evidence Sprint 2026, an intensive execution phase designed to turn cannabinoid science into usable medical evidence: protocols, operational collaboration, and projects ready for competitive funding.CBIH confirms receipt of a communication from the Centers for Medicare & Medicaid Services (CMS) acknowledging Company's meeting request with CMS Administrator Dr. Mehmet Oz a...

 PRESS RELEASE

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accele...

Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the launch of a national outreach and partnership initiative designed to capitalize on the accelerating federal momentum toward moving cannabis from Schedule I to Schedule III through the ongoing rescheduling rulemaking process. On December 18, 2025, a Presidential Executive Order directed the U.S. Attorney General to take necessary steps to complete the rulemaking process related to resche...

 PRESS RELEASE

CBIH Announces New Patent Initiative Targeting Opioid Addiction Throug...

Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that it is pursuing a new patent for an investigational therapy designed to address opioid addiction, a condition that continues to claim tens of thousands of lives each year in the United States.According to U.S. public health data, more than 700,000 people have died from opioid-involved overdoses since the early 2000s. Despite recent progress, the crisis remains severe: in 2024 alone, a...

 PRESS RELEASE

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Op...

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications that President Donald Trump will support federal actions that advance the rescheduling of marijuana from Schedule I to Schedule III. The development is widely regarded as one of the most consequential policy shifts in nearly two decades of national debate.After eighteen years of navigating scientific challenges, market volatility, stigma, and regulatory uncertainty, CBIH stated that this turn...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch